IGNYTA

Ignyta is a scientifically-driven biotechnology company catalyzing personalized medicine in autoimmune diseases. Their goal is to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions; and to identify truly novel autoimmune disease targets for biopharmaceutical companies to enable the development of precise therapies for patients worldwide. Ignyta was incorporated in 2011 and operates in San Diego, California.

#People #Financial #Event #Website #More

IGNYTA

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Health Diagnostics

Founded:

2011-01-01

Address:

San Diego, California, United States

Country:

United States

Website Url:

http://www.ignyta.com

Total Employee:

101+

Status:

Closed

Contact:

(858)255-5959

Email Addresses:

[email protected]

Total Funding:

375.5 M USD

Technology used in webpage:

SPF Domain Not Resolving IPv6 ReCAPTCHA Microsoft Azure DNS YouTube IIS DigiCert SSL Microsoft GoDaddy

Current Advisors List

heiner-dreismann_image

Heiner Dreismann Board of Directors @ Ignyta
Board_member

Current Employees Featured

james-l-freddo_image

James L. Freddo
James L. Freddo Director @ Ignyta
Director
2014-02-01

not_available_image

Jean-Michel Vernier
Jean-Michel Vernier Vice President, Medicinal Chemistry @ Ignyta
Vice President, Medicinal Chemistry

not_available_image

Robert Shoemaker
Robert Shoemaker Director of Bioinformatics @ Ignyta
Director of Bioinformatics

Founder

gary-firestein_image

Gary Firestein

jonathan-lim_image

Jonathan Lim

Stock Details

Company's stock symbol is NASDAQ:RXDX

Acquisitions List

Date	Company	Article	Price
2013-05-20	Actagene Oncology	Actagene Oncology acquired by Ignyta	N/A

Investors List

oxford-finance-corporation_image

Newest Events participated

Participated in Oncology Strategy Meeting Europe 2018 on 2018-05-22 as speaker

Official Site Inspections

http://www.ignyta.com

Host Informations
Whois Informations

Loading ...